index
Nasdaq-100
Large non-financial Nasdaq-listed companies
Index Battle · Evidence-first comparison
Nasdaq-100 vs FTSE All-World: Which Exposure Fits Your Portfolio?
Compare their structural exposure, diversification and intended portfolio role—without treating recent performance as a decision rule.
Last reviewed: 26 August 2026IndependentNo paid placementsInformational only
vs
index
FTSE All-World
Global developed and emerging-market equities
Overall verdict
Nasdaq-100 provides large non-financial nasdaq-listed companies, while FTSE All-World provides global developed and emerging-market equities. The decision is primarily about geographic or asset-class exposure, not which has recently performed better.
Quick Decision
Choose Nasdaq-100 if…
you deliberately want large non-financial nasdaq-listed companies and it matches the intended portfolio role.
Choose FTSE All-World if…
you deliberately want global developed and emerging-market equities and accept its distinct concentration and risks.
Either can make sense if…
the exposure, implementation and risks fit a clearly defined portfolio objective.
At a glance
Entity characteristics—not reference-product fees.
| Characteristic | Nasdaq-100 | FTSE All-World |
|---|---|---|
| Exposure | Large non-financial Nasdaq-listed companies | Global developed and emerging-market equities |
| Geography | United States | Global |
| Market coverage | Large cap | Large and mid cap |
| Emerging markets | Not included | Included |
| Small caps | Not included | Not included |
| Weighting | Modified market-cap weighted | Market-cap weighted |
| Index provider | Nasdaq | FTSE Russell |
Five key differences
- 1.Exposure: Large non-financial Nasdaq-listed companies compared with Global developed and emerging-market equities.
- 2.Geography: United States compared with Global.
- 3.Market coverage: Large cap compared with Large and mid cap.
- 4.Emerging markets: Not included compared with Included.
- 5.Weighting: Modified market-cap weighted compared with Market-cap weighted.
Decision scorecard
ExposureDepends
GeographyDepends
Market coverageDepends
Emerging marketsDepends
WeightingDepends
“Depends” means the category reflects an investor objective, not universal superiority.
Coverage, countries and sectors
Verified holdings, concentration, country and sector datasets are not currently connected. When available, each dataset will be labelled as official index data or Reference ETF holdings; listing domicile will not be presented as economic revenue exposure.
What this means in a portfolio
Holding both does not automatically create two independent portfolios. Overlapping companies and regions can make the combination an intentional tilt toward the exposure emphasised by FTSE All-World.
Common mistake
Assuming that adding FTSE All-World to Nasdaq-100 automatically improves diversification, without checking overlap and concentration.
Historical comparison basis
Historical performance is represented using Grovcap-selected reference exchange-traded products. It is not the official index or spot return series. Fund or ETP returns can differ because of fees, taxes, tracking, cash positions, product structure and other implementation effects. Differences can reflect TER, tracking difference, withholding taxes, sampling, securities lending, cash drag, operating expenses, currency conversion and inception date.
| Period | Nasdaq-100 | FTSE All-World | Basis |
|---|---|---|---|
| Year to date | 20.07% | 11.18% | Cumulative |
| 1 year | 33.85% | 23.58% | Cumulative |
| 3 years | 26.30% | 19.66% | Annualised |
| 5 years | 16.19% | 10.96% | Annualised |
| Since inception | 19.36% | 13.16% | Annualised |
Provider-reported net-asset-value total returns for the two reference products, in USD, as of 30 Jun 2026. Figures are taken from provider documents; Grovcap does not convert them into another currency and does not recompute them. Periods where the two products report different currencies, bases or reporting dates are withheld rather than aligned artificially.
Grovcap does not currently hold a daily net-asset-value time series for these products. Indexed performance charts, annualised volatility, maximum drawdown and return-per-risk therefore remain unavailable rather than being estimated from period returns.
Reference instruments used
One canonical European exchange-traded product per exposure, chosen by published rules: exact benchmark family, active and published, plain long-only, then accumulating, unhedged, longest usable history and largest established product.
Nasdaq-100 reference product
iShares NASDAQ 100 UCITS ETF
- ISIN
- IE00B53SZB19
- Product type
- UCITS ETF
- Provider
- Ishares
- Tracked benchmark
- NASDAQ 100 Index
- Distribution
- Accumulating
- Currency hedging
- Unhedged
- Replication
- Replicated
- Domicile
- Ireland
- Base currency
- USD
- Ongoing charge (TER)
- 0.30%
- Fund size
- $26.89bn
- Inception
- 26 Jan 2010
Selected deterministically from 15 eligible products in the Grovcap database — never by commercial arrangement.
FTSE All-World reference product
Vanguard FTSE All-World UCITS ETF (USD) Accumulating
- ISIN
- IE00BK5BQT80
- Product type
- UCITS ETF
- Provider
- Vanguard
- Tracked benchmark
- Not currently available
- Distribution
- Accumulating
- Currency hedging
- Unhedged
- Replication
- Index
- Domicile
- Ireland
- Base currency
- USD
- Ongoing charge (TER)
- 0.19%
- Fund size
- Not currently available
- Inception
- 23 Jul 2019
Selected deterministically from 9 eligible products in the Grovcap database — never by commercial arrangement.
Continue researching
Related Grovcap guides, rankings and tools to take the next step.
Best ETFsBest Nasdaq-100 UCITS ETFsA distinct, concentrated US equity exposure compared on cost and structure.Best ETFsBest FTSE All-World UCITS ETFsEvery core FTSE All-World UCITS share class compared on cost, size and structure.ETF comparisonVWCE vs WEBNFTSE and Solactive all-country implementations compared.ETF comparisonIWDA vs VWCEDeveloped-world versus all-world coverage, cost and portfolio fit.PortfolioIs One All-World ETF Enough?Separate genuine diversification from overlap and intentional tilts.
Disclaimer
The information provided by Grovcap is for informational and educational purposes only and does not constitute investment, financial, legal, or tax advice. Investing involves risk, including the possible loss of capital. Always conduct your own research or consult a qualified professional before making investment decisions.
Your responses to quizzes, surveys, and other interactive features may be used in aggregated and anonymized form to improve Grovcap and generate investor insights. We do not sell personally identifiable information to third parties. For more information about how we collect, use, and protect your data, please refer to our Privacy Policy.